FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,841 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,860

 

Start Prev Rows 2400 - 2600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2333Atrioventricular septal defect (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2334Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2335Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2336Tricuspid valve atresia (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2337Tricuspid valve atresia (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2338Tricuspid valve stenosis (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2339Tricuspid valve stenosis (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2340Fetal Tricuspid valve stenosis (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2341Exposure to Measles (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2342Increased Risk for Exposure to Measles (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2343Giardiasis (Tests by Microscopic Observation)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2344Diphtheria (Tests for Diphtheria Toxin Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2345Lead in Blood (Tests for Lead in Venous Blood)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2346Lead in Blood (Tests for Lead in Capillary Blood)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2347Opioid Overdose and Poisoning (Test Panels for Opioids)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2348Rubella (Test Panels for rubella virus IgM Antibody)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2349Consistent with Tuberculosis (Finding in Chest Xray Imaging Results)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2350Acute Viral Hepatitis (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2351Shigellosis (Combination Tests that include Shigella species by Culture and Identification)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2352Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2353Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2354Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2355Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2356Skin (Specimen Type) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2357Organisms (Tests by Microscopic Observation in Skin)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2358Unspecified Tissue (Specimen Type) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2360S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2361S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2368Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2369Necrotizing Fasciitis (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2370Necrotizing Fasciitis (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2371Renal Impairment [Acute or Unspecified] (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2372Renal Impairment [Acute or Unspecified] (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2373Coagulopathy [Unspecified Cause] (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2374Coagulopathy [Unspecified Cause] (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2375Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2376Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2377Soft Tissue Necrosis (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2378Soft Tissue Necrosis (ICD10CM)active2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2379Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2380Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2381Specimen from a Nonsterile Site (Specimen Type) (SNOMED)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2382Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2383Absence of Skin Lesions (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2384Neuralgia (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2385Neuralgia (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2386Peripheral Nerve Thickening (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2387Nerve (Specimen Type) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2388Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.239Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.240Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen)active2023-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2403NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2404Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2405Hepatitis D Virus Infection (Test for hepatitis D virus Antigen)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2406Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2407Firearm Injury (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2408Firearm Injury (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2409Babesiosis (Tests for B. microti IgG or Total Antibody [Titer])active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2410Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer])active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2411Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer])active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2412Babesiosis (Tests for Babesia species IgG or Total Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2413Brucellosis (Tests for Brucella species IgG Antibody by ELISA)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2414Cranial Nerve Involvement (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2415Cranial Nerve Involvement (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2416Unusual Change in Behavior (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2417Radiculitis (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2418Subarachnoid Hemorrhage (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2419Subarachnoid Hemorrhage (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2420Discitis (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2421Discitis (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2423Respiratory Insufficiency [Unspecified Cause] (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2424Respiratory Insufficiency [Unspecified Cause] (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2425Conjunctival Suffusion (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2426Leptospira species (Tests by Microscopic Observation)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2427Leptospirosis (Tests for Leptospira Antibody by Agglutination)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2428Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2429Conjunctival Suffusion (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2430Pleural effusion (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2431Pleural effusion (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2432Abdominal swelling (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2433Abdominal swelling (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2434Neck swelling (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2435Neck swelling (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2436Diaphoresis (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2437Diaphoresis (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2438Edema (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2439Edema (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.244Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2440Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2441Anthrax (Tests for Bacillus species by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2442Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2443Influenza A (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2444Influenza B (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2445Influenza [Unspecified] (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2446Influenza A (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2447Influenza [Unspecified] (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2448Influenza (Tests for unspecified influenza virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2449Influenza (Tests for influenza B virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2450Influenza (Tests for unspecified influenza virus Antigen)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2451Influenza (Tests for influenza B virus Antigen)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2452Influenza (unspecified influenza virus in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2453Influenza (influenza B virus in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2454Influenza (Tests for unspecified influenza virus by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2455Influenza (Tests for influenza B virus by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2456Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2457Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2458Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2459Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2460Borrelia species (Tests by Microscopic Observation)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2461Borrelia species (Tests by Microscopic Observation in Blood)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2462Spirochetes (Tests by Microscopic Observation)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2463Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2464CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2465CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2466CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2467CRE (Tests for Enterobacterales species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2468CRE (Combination Tests that include Enterobacterales by Culture and Identification)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2469Tests for Carbapenem Susceptibility [Meropenem and Doripenem]active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2470Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2471Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2473Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2474Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2475Aortic valve stenosis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2476Aortic valve stenosis (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2477Anotia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2478Microtia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2479Microtia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2480Anotia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2482Anophthalmia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2483Anophthalmia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2484Microphthalmia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2485Microphthalmia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2486Atrial septal defect (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2487Atrial septal defect (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2488Fetal Aortic valve stenosis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2489Congenital Posterior Urethral Valves (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2490Congenital Posterior Urethral Valves (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2491Bladder Exstrophy (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2492Bladder Exstrophy (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2493Encephalocele (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2494Fetal Encephalocele (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2495Encephalocele (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2496Choanal Atresia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2497Choanal Atresia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2498Cloacal Exstrophy (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2499Cloacal Exstrophy (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2500Renal Agenesis or Hypoplasia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2501Renal Agenesis or Hypoplasia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2502Trisomy 13 (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2503Trisomy 13 (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2504Fetal Trisomy 13 (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2505Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2506Galactosemia (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2507Galactosemia (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2508Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2509Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2510Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2511Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative])active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2512Galactosemia (Tests for Galactokinase (GALK) [Quantitative])active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2513Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative])active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2514Galactosemia (Tests for GALT gene allele 1)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2515Galactosemia (Tests for GALT gene allele 2)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2516Hypospadias (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2517Hypospadias (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2518Trisomy 18 (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2519Fetal Trisomy 18 (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2520Fetal Trisomy 18 (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2521Trisomy 18 (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2522Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2523Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2524Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2525Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2526Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2527Chlamydia species [Unspecified] (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2528Ventricular septal defect (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2529Ventricular septal defect (Disorders) (ICD10CM)active2025-02hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2530Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2531Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2532Congenital Cytomegalovirus (Tests for CMV Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2533Congenital Cytomegalovirus (Tests for CMV Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.268Mumps (Tests for mumps virus IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.272Present or Positive Lab Result Valueactive2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.282Varicella (Tests for Varicella zoster virus by Culture and Identification Method)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.283Varicella (Tests for Varicella zoster virus Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.285Encephalitis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.287Varicella (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.289Carbon Monoxide Poisoning (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.293Toxic Effects of Lead (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.297Measles (Tests for measles virus Nucleic Acid)active2025-03hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.299Measles (Tests for measles virus IgM Antibody)active2025-03hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.300Meningococcal Disease (Organism or Substance in Lab Results)active2023-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.301Shigellosis (Tests for Shigella species by Culture and Identification Method)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.307Leptospirosis (Tests for Leptospira IgM Antibody)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.308Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)active2023-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.310Bacteria (Tests by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.311Viruses (Tests by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.316Rubella (Tests for rubella virus IgM Antibody)active2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.317Shigellosis (Tests for Shigella species Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.319Fungi (Tests by Culture and Identification Method)active2024-01hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.322Pesticide Related Illness (Disorders) (ICD10CM)active2023-01hl7icd